GoodRx Holdings reports mixed Q3 earnings; initiates Q4 and FY23 outlook (NASDAQ:GDRX)

Outlook: For the fourth quarter and full yr 2023, and full yr 2024, administration is anticipating the next:

$ in thousands and thousands	4Q 2023	4Q 2022	YoY Change
Income^{5 vs. consensus of $192.67M}	$188-$194	$184.1	2%-5%
Adjusted Income⁵	$188-$194	$184.1	2%-5%
Adjusted EBITDA Margin⁶	Mid-to-high twenty-percent vary

$ in thousands and thousands	FY 2023	FY 2022	YoY Change
Income^{5 vs. consensus of $754.94M}	$742-$748	$766.6	(3%)-(2%)
Adjusted Income⁵	$752-$758	$766.6	(2%)-(1%)
Adjusted EBITDA Margin⁶	Excessive twenty-percent vary

Treasury’s recent moves in the bond and currency markets add up to ‘soft-form financial repression’